跳到正文

公司

Everest Medicines

简介

总部
CN

Everest Medicines 的结构

Everest Medicines

公司

12 个关联
上游供应与依赖3 / 4
自有产品与技术
下游客户5 / 8
关系出现时间2026
Everest Medicines公司 · 12 个关联
第 1 层

上游供应与依赖3

下游客户5

自有产品与技术4

在关系网络中的位置

第 98 位,共 15437 个前 1%

11 条直接关系

所在群组共 61 个紧密关联的对象,核心是

按有证据的公开关系计算,每天更新。

关系

箭头表示关系方向,可按业务类别筛选。

  • Everest Medicines经营于 →United States
    事实98%
    查看证据
    • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
      查看来源
    • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      expand Everest's presence in the United States
      查看来源
  • Everest Medicines使用 →mRNA
    事实96%
    查看证据
    • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
      查看来源
    • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
      查看来源
    • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline
      查看来源
  • Everest Medicines经营于 →oncology
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.
      查看来源
  • 事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09 10:13
      a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative pharmaceutical products
      查看来源
  • Everest Medicines使用 →Lipid nanoparticles
    事实90%
    查看证据
    • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Everest has established and optimized its proprietary LNP delivery system, with patent coverage including ionizable lipids and stealth lipids.
      查看来源
  • Everest Medicines经营于 →autoimmune disease
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary AI+mRNA platform, Everest is advancing multiple mRNA therapeutic vaccine and in vivo CAR-T programs across oncology and autoimmune diseases.
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.
      查看来源
  • Everest Medicines使用 →mRNA technology
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
      查看来源
    • 公司披露PR Newswire news releases2026-10-09 10:13
      Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline, including mRNA in vivo CAR-T and mRNA cancer vaccines
      查看来源
  • Everest Medicines经营于 →Ophthalmology
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09 10:13
      The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases.
      查看来源

显示第 1 至 8 条,共 18 条

结论

结合来源阅读结论,展开条目查看证据。

事实证据 1

暂无可公开的证据摘要。

GDELT Global Knowledge Graph · 2026-10-10 13:45

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
    查看来源
事实证据 3
经营于United States

expand Everest's presence in the United States

GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
    查看来源
  • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
    查看来源
  • 公司披露PR Newswire news releases2026-10-09 10:13
    expand Everest's presence in the United States
    查看来源
事实证据 5
使用mRNA

Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.

GDELT Global Knowledge Graph · PR Newswire news releases · 2026-10-10 13:45

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
    查看来源
  • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
    查看来源
  • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
    查看来源
  • 公司披露PR Newswire news releases2026-10-09 10:13
    Everest has built an industry-leading and fully integrated AI+mRNA platform that accelerates mRNA product development.
    查看来源
  • 公司披露PR Newswire news releases2026-10-09 10:13
    Leveraging its proprietary mRNA platform, the Company is advancing its existing pipeline
    查看来源
事实证据 1

暂无可公开的证据摘要。

GDELT Global Knowledge Graph · 2026-10-10 13:45

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-10 13:45
    查看来源
事实证据 1

暂无可公开的证据摘要。

GDELT Global Knowledge Graph · 2026-10-09 16:15

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-09 16:15
    查看来源
事实证据 1

暂无可公开的证据摘要。

GDELT Global Knowledge Graph · 2026-10-09 12:45

查看证据
  • 媒体GDELT Global Knowledge Graph2026-10-09 12:45
    查看来源

显示第 1 至 6 条,共 21 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

暂无: 公司信号 · 财务数据 · 披露文件 · 业绩指引